* See Tables A and B at the end of this release for reconciliation of adjusted amounts to GAAP. "Our CRM, Neuromodulation, Vascular Access and Electrochem product line revenue were generally in line with initial expectations,” stated Thomas J. Hook, Greatbatch’s President & Chief Executive Officer.